Scarica l'app Stockscreener
1.8207
39.77%
0.5007
Precedente Chiudi:
$1.32
Aprire:
$2.335
Volume 24 ore:
106.14M
Relative Volume:
97.05
Capitalizzazione di mercato:
$35.07M
Reddito:
-
Utile/perdita netta:
$-11.24M
Rapporto P/E:
-2.3909
EPS:
-0.7615
Flusso di cassa netto:
$-4.79M
1 W Prestazione:
+37.69%
1M Prestazione:
+40.84%
6M Prestazione:
+72.43%
1 anno Prestazione:
+67.73%
Intervallo 1D:
$1.65
$2.45
Intervallo di 1 settimana:
$1.25
$2.45
Portata 52W:
$0.73
$2.56
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Nome
Mira Pharmaceuticals Inc
Settore
Industria
Telefono
813-369-5150
Indirizzo
1200 BRICKELL AVENUE, MIAMI
Confronta MIRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.8389 | 24.98M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
819.50 | 728.24B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
192.27 | 459.63B | 92.15B | 25.12B | 18.18B | 10.36 |
|
ABBV
Abbvie Inc
|
227.00 | 404.77B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
130.81 | 252.16B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
83.89 | 211.56B | 63.43B | 16.42B | 14.72B | 6.4861 |
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
MIRA Pharmaceuticals’ Mira-55 Outperforms Morphine in Study - TipRanks
Can MIRA Pharmaceuticals Inc. stock sustain free cash flow growth2025 Earnings Impact & Short-Term High Return Ideas - newser.com
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation - The Courier-Journal
Is MIRA Pharmaceuticals Inc. stock a contrarian buy2025 Price Targets & Precise Trade Entry Recommendations - newser.com
Trend analysis for MIRA Pharmaceuticals Inc. this weekMarket Performance Recap & Verified Technical Trade Signals - newser.com
Published on: 2025-10-13 23:42:35 - newser.com
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - GoUpstate
How to monitor MIRA Pharmaceuticals Inc. with trend dashboardsRisk Management & Daily Growth Stock Tips - newser.com
How to manage a losing position in MIRA Pharmaceuticals Inc.Weekly Trend Recap & Community Trade Idea Sharing - newser.com
Published on: 2025-10-13 08:57:32 - newser.com
Price momentum metrics for MIRA Pharmaceuticals Inc. explainedWeekly Trade Recap & Community Verified Trade Signals - newser.com
Should you wait for a breakout in MIRA Pharmaceuticals Inc.2025 Technical Overview & Smart Investment Allocation Tips - newser.com
Can MIRA Pharmaceuticals Inc. stock surprise with earnings upsideFed Meeting & High Accuracy Swing Entry Alerts - newser.com
MIRA Pharmaceuticals reports positive in vitro drug release data for topical Ketamir-2 - MSN
What drives MIRA Pharmaceuticals Inc stock priceStock Price Targets & Budget Investment Success - earlytimes.in
Is MIRA Pharmaceuticals Inc. stock a buy in volatile marketsMarket Sentiment Report & Technical Pattern Alert System - newser.com
MIRA Pharmaceuticals Inc. stock daily chart insightsPortfolio Profit Report & Precise Swing Trade Alerts - newser.com
What machine learning models say about MIRA Pharmaceuticals Inc.Weekly Risk Summary & Proven Capital Preservation Tips - newser.com
MIRA Pharmaceuticals Inc Stock Analysis and ForecastTechnical Resistance Breaks & Free Hedging Tactics for Volatile Markets - earlytimes.in
Published on: 2025-10-09 04:14:21 - newser.com
Is MIRA Pharmaceuticals Inc. reversing from oversold territory2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
What analysts say about MIRA Pharmaceuticals Inc stockEquity Performance Review & Low Cost Trading Plans - earlytimes.in
What indicators show strength in MIRA Pharmaceuticals Inc.Market Performance Recap & AI Optimized Trading Strategy Guides - newser.com
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - Fall River Herald News
Is MIRA Pharmaceuticals Inc. a candidate for recovery playPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals - El Paso Times
What data driven models say about MIRA Pharmaceuticals Inc.’s futureWeekly Profit Analysis & Consistent Growth Equity Picks - newser.com
Using fundamentals and technicals on MIRA Pharmaceuticals Inc.Market Activity Report & Fast Moving Stock Watchlists - newser.com
Analyzing MIRA Pharmaceuticals Inc. with multi timeframe chartsJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Rating Upgraded by Wall Street Zen - Defense World
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction - The Oklahoman
Custom strategy builders for tracking MIRA Pharmaceuticals Inc.July 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
MIRA Pharmaceuticals Completes SKNY Acquisition - MSN
What moving averages say about MIRA Pharmaceuticals Inc.New Guidance & Free Safe Entry Trade Signal Reports - newser.com
MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals By Investing.com - Investing.com Nigeria
Mira Pharmaceuticals Inc Azioni (MIRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mira Pharmaceuticals Inc Azioni (MIRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Aminov Erez | Chief Executive Officer |
Nov 20 '24 |
Sale |
1.27 |
44,590 |
56,629 |
1,061,200 |
2.13%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):